Neurosense Therapeutics Ltd (NRSN)

US · Healthcare · Biotechnology

$3.07-3.15%

Last close · 2026-10-16

Key statistics

Market cap

$5.8M

Forward P/E

0.0

P/B

2.64

Book value

$-0.96

EPS (TTM)

$-44.40

52-week high

$26.62

52-week low

$2.87

50-day MA

$7.01

200-day MA

$13.80

Beta

1.64

Analysts rate Neurosense Therapeutics Ltd a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $97.33.

Insiders

31.42%

Institutions

1.05%

Fund	Stake
UBS Group AG	0.29%
Independent Advisor Alliance	0.26%
Yorkville Advisors Global, LP	0.21%
Commonwealth Equity Services, LLC	0.06%
PNC Financial Services Group Inc	0.06%
Pathstone Holdings LLC	0.04%
Geode Capital Management, LLC	0.04%
XTX Topco Ltd	0.03%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Neurosense Therapeutics Ltd — free to start.

Data updated 2026-10-19.